skip to content


Eczema, GRAPHITE PENTARKAN S tablets

DHU-Arzneimittel GmbH & Co. KG

Sale price £40.80 Regular price £50.00

Tax included. Shipping calculated at checkout.

GRAPHITE PENTARKAN S tablets, Eczema

pack size:200 pcs Dosage form:tablets

Homeopathic medicine

active Eczema, GRAPHITE PENTARKAN S tablets ingredients

  • 25 mg Sulfur D4
  • 25 mg Causticum Hahnemanni D3
  • 25 mg Mercurius solubilis Hahnemanni D8
  • 25 mg Acidum arsenicosum D5
  • 25 mg Graphites D3

Eczema, GRAPHITE PENTARKAN S tablets excipients

  • magnesium stearate
  • wheat starch
  • lactose-1 water

 

indication Eczema, GRAPHITE PENTARKAN S tablets

 

  • The area of ​​application is derived from the homeopathic drug pictures. These include: Eczema.

 

dosage Eczema, GRAPHITE PENTARKAN S tablets

 

  • Unless otherwise prescribed:
    • For acute symptoms until improvement occurs:
      • 1 tablet every hour (maximum 12 times a day).
    • If symptoms subside or in chronic cases:
      • 1 tablet 1 to 3 times a day

side effects

  • After application, increased salivation may occur. The drug should then be discontinued. Because of the mercury (mercury) component, allergic reactions may occasionally occur.
  • A notice:
    • When taking a homeopathic medicine, the existing symptoms can temporarily worsen (initial aggravation). In this case, the drug should be discontinued and a doctor should be consulted.

Contraindications

  • Taking this medicine may be harmful to people with celiac disease due to the wheat starch content.

pregnancy Eczema, GRAPHITE PENTARKAN S tablets and breast feeding period

  • Since there is no sufficiently documented experience, the drug should only be used during pregnancy and breastfeeding after consulting a doctor.

patient Eczema, GRAPHITE PENTARKAN S tablets notes

  • If the drug is used as intended, no special precautions are required.
  • There is insufficient documented experience with the use of this medicine in children. It should therefore not be used in children under the age of 12.
  • Since there is no sufficiently documented experience, the drug should only be used during pregnancy and breastfeeding after consulting a doctor.